The Minnesota Department of Health announced Monday that it was adding Alzheimer’s disease to the state’s medical marijuana program.
“[T]here is some evidence for potential benefits of medical cannabis to improve the mood, sleep and behavior of patients suffering from Alzheimer’s disease.”, said state Health Commissioner Jan Malcolm, who made the final decision to add the disease to medical marijuana program. The move allows those with the Alzheimer’s who receive a recommendation from a physician to legally purchase, possess and use cannabis and cannabis products for medical use.
Unfortunately Malcolm declined to add six other conditions that were submitted by a state advisory panel; these were opioid use disorder, hepatitis C, juvenile rheumatoid arthritis, panic disorder, psoriasis and traumatic brain injury.
- Cancer associated with severe/chronic pain, nausea or severe vomiting, or cachexia or severe wasting
- Tourette’s syndrome
- Amyotrophic lateral sclerosis (ALS)
- Seizures, including those characteristic of epilepsy
- Severe and persistent muscle spasms, including those characteristic of multiple sclerosis
- Inflammatory bowel disease, including Crohn’s disease
- Terminal illness, with a probable life expectancy of less than one year
- Intractable pain
- Post-traumatic stress disorder
- Autism spectrum disorders
- Obstructive sleep apnea
The post Minnesota Adds Alzheimer’s Disease as Qualifying Medical Cannabis Condition appeared first on TheJointBlog.